3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Neoplasms
1
Motor Activity
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma
1
Leukemia
1
Dementia
1
Cognitive Dysfunction
1
Alzheimer Disease
1
Interventions
Exercise
22
Resistance Training
2
Methods
2
Diet
2
secukinumab
1
peficitinib
1
blueberry extract
1
Wearable Electronic Devices
1
Walking
1
Tablets
1
Surveys and Questionnaires
1
Roflumilast
1
Psychosocial Intervention
1
Psychology, Positive
1
Nadolol
1
Mindfulness
1
Masks
1
Isoproterenol
1
Hematologic Tests
1
Hand Strength
1
Exercise Therapy
1
Carvedilol
1
Cardiac Output
1
Body Composition
1
Bisoprolol
1
Andrographis paniculata extract
1
Accelerometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Motor Activity
×
Tablets
×
Lymphoid
×
Clear all
NCT06643221
2024-10-16
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
100 enrolled